홈 › 급성 골수성 백혈병 › 오하이오 › Cincinnati
OH Cincinnati의 급성 골수성 백혈병 임상 시험
급성 골수성 백혈병 관련 연구 20개가 Cincinnati 및 인근(약 30마일 이내) 지역에서 참여자를 모집하고 있습니다. 연구 항목을 열어 참여 자격 및 연구 팀 연락처를 확인하세요.
공식 연구 텍스트(영어)
연구 대상자를 모집 중이신가요? 이 페이지 상단에 노출하세요 — 30일 동안 $99 →
Bleximenib in Combination With Standard Induction and Consolidation Therapy Followed by Maintenance for Treatment of Patients With Acute Myeloid Leukemia (AML)
피험자 모집 중3상
- US-Cincinnati OH-CINCY, Cincinnati
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
피험자 모집 중관찰 연구건강한 지원자 환영
- Good Samaritan Hospital - Cincinnati, Cincinnati
- Oncology Hematology Care Inc-Kenwood, Cincinnati
- Bethesda North Hospital, Cincinnati
- 외 3개
A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)
피험자 모집 중3상
- Oncology Hematology Care, Cincinnati
Mocravimod as Adjunctive and Maintenance Treatment in AML Patients Undergoing Allo-HCT
피험자 모집 중3상
- University of Cincinnati Medical Center (University Hospital), Cincinnati
Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
피험자 모집 중관찰 연구
- Cincinnati Children's Hospital Medical Center, Cincinnati
A Study to Find the Highest Dose of Cedazuridine and Decitabine Combination With Filgrastim as a Treatment Option After Hematopoietic Stem Cell Transplant in Children With High-Risk Acute Myeloid Leukemia
피험자 모집 중1상
- Cincinnati Children's Hospital Medical Center, Cincinnati
Study of Revumenib, Azacitidine, and Venetoclax in Pediatric and Young Adult Patients With Refractory or Relapsed Acute Myeloid Leukemia
피험자 모집 중1상
- Cincinnati Children's Hospital Medical Center, Cincinnati
A Longitudinal Multi-Center Molecular Biomarker Discovery Registry for Patients With Hematologic Malignancies
피험자 모집 중관찰 연구
- University of Cincinnati, Cincinnati
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
피험자 모집 중3상
- Cincinnati Children's Hospital Medical Center, Cincinnati
Revumenib in Combination With Azacitidine + Venetoclax in Patients NPM1-mutated or KMT2A-rearranged AML
피험자 모집 중3상
- US-Cincinnati OH-CINCY, Cincinnati
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
피험자 모집 중1/2상
- Cincinnati Children's Hospital Medical Center, Cincinnati
A Phase 1b Study of Menin Inhibitor SNDX- 5613 in Combination With Daunorubicin and Cytarabine in Newly Diagnosed Patients With Acute Myeloid Leukemia and NPM1 Mutated/FLT3 Wildtype or MLL/KMT2A Rearranged or NUP98 Alterations Disease
피험자 모집 중1상
- University of Cincinnati Cancer Center-UC Medical Center, Cincinnati
- University of Cincinnati Cancer Center-West Chester, West Chester · 15마일 거리
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
피험자 모집 중관찰 연구
- Cincinnati Children's Hospital, Cincinnati
Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL.
피험자 모집 중1상
- Cincinnati Children's Hospital Medical Center, Cincinnati
- University of Cincinnati, Cincinnati
Study of Talazoparib in Combination With Chemotherapy in Relapsed Pediatric AML to Determine Safety and Efficacy
피험자 모집 중1상
- Cincinnati Children's Hospital, Cincinnati
Cytokine-Induced Memory-Like Natural Killer Cells (CIML-NK) for Relapsed & Refractory Acute Myeloid Leukemia (AML)
피험자 모집 중1/2상
- Cincinnati Children's Hospital Medical Center, Cincinnati
Venetoclax Combined With Vyxeos (CPX-351) for Participants With Relapsed or Refractory Acute Leukemia
피험자 모집 중1상
- Cincinnati Children's Hospital Medical Center, Cincinnati
HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy
피험자 모집 중2상
- Cincinnati Children's Hospital Medical Center, Cincinnati
APVO436 Phase 1b/2 Study in Patients With Newly Diagnosed AML
피험자 모집 중1상
- Oncology Hematology Care, Cincinnati
Study of VIP943 in Subjects With Advanced CD123+ Hematologic Malignancies
피험자 모집 중1상
- University of Cincinnati, Cincinnati
다른 도시의 급성 골수성 백혈병 시험
- Houston, TX연구 88개
- New York City, NY연구 51개
- Boston, MA연구 44개
- Baldwin Park, CA연구 41개
- Seattle, WA연구 40개
- Durham, NC연구 34개
- Columbus, OH연구 34개
- Philadelphia, PA연구 33개
- Atlanta, GA연구 30개
- Tampa, FL연구 30개
- Chicago, IL연구 27개
- Los Angeles, CA연구 25개
Cincinnati의 다른 연구
- 비소세포폐암연구 31개
- 암 (전체)연구 26개
- 유방암연구 24개
- 심부전연구 22개
- 전이성 암연구 21개
- 대장직장암연구 20개
- 비만연구 20개
- 전립선암연구 19개
- 난소암연구 18개
- 폐암연구 18개
- 다발성 골수종연구 17개
- 심혈관 질환연구 16개
ClinicalTrials.gov 출처, 2026. 11. 15. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.